Tamar Thompson
CIK 1839248 · last filed 2026-02-27
Tamar Thompson is a corporate insider who has filed 12 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for RNAM, was dated Feb 27, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $201.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$201.1K
3
12
-$1.35M
Holdings By Company
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) Delisted | Disp (D) | −6,692 | $0 | EDGAR |
| 2025-12-10 | CPRX | Exer (M) | +1,413 | $0 | EDGAR |
| 2025-11-24 | CPRX | Mixed | +947 | $0 | EDGAR |
| 2025-06-12 | RNA | Grant (A) | +6,692 | $0 | EDGAR |
| 2024-12-11 | CPRX | Exer (M) | +1,413 | $0 | EDGAR |
| 2024-11-25 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2024-10-09 | RNA | Mixed | — | -$520.4K | EDGAR |
| 2024-06-14 | RNA | Grant (A) | — | $0 | EDGAR |
| 2023-12-12 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | RNA | Grant (A) | — | $0 | EDGAR |